| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on April 8, 2004
From the University of South Alabama Stroke Center (R.M.Z., M.A.M., M.P.), Mobile, Ala; and Medivance, Inc. (M.E.V.), Louisville, Colo. * To whom correspondence should be addressed. E-mail: rzweifle{at}usouthal.edu.
Background and Purpose--Therapeutic hypothermia shows promise as a treatment for acute stroke. Surface cooling techniques are being developed but, although noninvasive, they typically achieve slower cooling rates than endovascular methods. We assessed the hypothesis that the addition of intravenous MgSO4 to an antishivering pharmacological regimen increases the cooling rate when using a surface cooling technique. Methods--Twenty-two healthy volunteers were studied. Hypothermia was induced using a surface technique with a target tympanic temperature (Ttym) of 34.5°C (target range 34 to 35°C). Subjects received 1 of the following pharmacological regimens: (1) meperidine monotherapy (n=5); (2) meperidine plus buspirone, 30 to 60 mg PO administered at the time of initiation of cooling (n=4); (3) meperidine and ondansetron, 8 to 16 mg IV administered as an 8 mg bolus at the time of initiation of cooling with an optional second dose after 4 hours as needed for nausea (n=5); or (4) meperidine, ondansetron, and MgSO4, 4 to 6 g IV bolus followed by 1 to 3 g per hour infusion (n=8). Thermal comfort was evaluated with a 100-mm-long visual analog scale. Results--More subjects who received MgSO4 were vasodilated during hypothermia induction (7 of 8 [88%] versus 4 of 14 [29%]; P=0.024). MgSO4 (coefficient -17.265; P=0.039), weight (1.838, 0.001), and the initial 2-hour meperidine dose (0.726, 0.003) were found to significantly impact the time to achieve Ttym of 35°C. Subjects who received MgSO4 had significantly higher mean comfort scores than those who did not (48±15 versus 38±12; P<0.001). Conclusions--Administration of intravenous MgSO4 increases the cooling rate and comfort when using a surface cooling technique.
Revised on June 5, 2004
Accepted on July 7, 2004
Magnesium Sulfate Increases the Rate of Hypothermia Via Surface Cooling and Improves Comfort
Richard M. Zweifler MD*;
This article has been cited by other articles:
![]() |
A. Wadhwa, P. Sengupta, J. Durrani, O. Akca, R. Lenhardt, D. I. Sessler, and A. G. Doufas Magnesium sulphate only slightly reduces the shivering threshold in humans Br. J. Anaesth., June 1, 2005; 94(6): 756 - 762. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |